FeaturedNeurosciencePsychology·March 30, 2026·8 min readBlocking NOX-1 Extends Ketamine’s Effectiveness for DepressionResearchers have identified the NOX-1 enzyme as the reason ketamine's antidepressant effects are short-lived. By blocking NOX-1, they extended the drug's benefits from days to weeks.Read More
FeaturedNeurosciencePsychology·March 28, 2026·11 min readCan Deep Brain Stimulation Unlock Treatment-Resistant Depression?Researchers are testing Deep Brain Stimulation (DBS) for treatment-resistant depression. By acting as a "brain pacemaker," the device targets white matter to help patients who haven't found relief from standard medications or therapy.Read More
